secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nemaura Medical Inc. (—)
CIK:        0001602078
Form:       8-K
Filed at:   2023-10-06T23:59:59+00:00
Accession:  0001079973-23-001393
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nemaura Medical receives Nasdaq delisting notices for MVLS and bid price non-compliance
--------------------------------------------------------------------------------

- Received notice on Oct 3-4, 2023 for failing to meet $35M MVLS and $1 bid price requirements.
- Grace periods expired Oct 2 (MVLS) and Oct 3 (bid price) without regaining compliance.
- Company intends to request a hearing before Nasdaq Hearings Panel to stay delisting.
- Panel may grant extension until April 1, 2024; no assurance of continued listing.
- Common stock (NMRD) expected to trade on Nasdaq through hearings process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1602078/000107997323001393/0001079973-23-001393-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1602078/000107997323001393/nmra_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-23-001393

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer